"WITNESS FOR THE PROSECUTION:" DEVELOPMENT AND IMPLEMENTATION OF PSYCHOTROPIC MEDICATION OVERSIGHT: THE CALIFORNIA MODEL

被引:0
|
作者
Fouras, George A. [1 ]
机构
[1] Los Angeles Cty, Los Angeles, CA USA
关键词
D O I
10.1016/j.jaac.2018.07.328
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
54.4
引用
收藏
页码:S78 / S78
页数:1
相关论文
共 50 条
  • [31] IMPLEMENTATION OF A MODEL FOR THE MEDICATION RECONCILIATION PROCESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Mendez, Karol
    Urrego, Jose
    Villarreal, Laura
    Buitrago, Diana
    Santos-Moreno, Pedro
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S93 - S94
  • [32] A new mouse model of ADHD for medication development
    Majdak, Petra
    Ossyra, John R.
    Ossyra, Jessica M.
    Cobert, Adam J.
    Hofmann, Gabrielle C.
    Tse, Stephen
    Panozzo, Brent
    Grogan, Elizabeth L.
    Sorokina, Anastassia
    Rhodes, Justin S.
    SCIENTIFIC REPORTS, 2016, 6
  • [33] Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent-onset bipolar disorder
    Jerrell, Jeanette M.
    McIntyre, Roger S.
    Tripathi, Avnish
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (07) : 451 - 459
  • [34] Development of practice-guided measures to improve guideline adherence in psychotropic medication for adults with intellectual disabilities
    Schuetzwohl, Matthias
    Kroenke, Indra
    Reupert, Annegret
    Stasch, Nicole
    Mayer, Lea
    Krumm, Silvia
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL DISABILITIES, 2023,
  • [35] How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication
    Groot, Peter C.
    van Os, Jim
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2020, 10
  • [36] A new mouse model of ADHD for medication development
    Petra Majdak
    John R. Ossyra
    Jessica M. Ossyra
    Adam J. Cobert
    Gabrielle C. Hofmann
    Stephen Tse
    Brent Panozzo
    Elizabeth L. Grogan
    Anastassia Sorokina
    Justin S. Rhodes
    Scientific Reports, 6
  • [37] Development of the medical adherence scale in adolescents using psychotropic medication and evaluation of validity and reliability in Turkish population
    Dikec, Gul
    Bilac, Oznur
    Sonkaya, Hilal Isleyen
    Aydemir, Omer
    JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2024, 78 : 118 - 123
  • [38] Impact of the emotional development approach on psychotropic medication in adults with intellectual and developmental disabilities: a retrospective clinical analysis
    Barrett, B. F.
    Wehmeyer, M.
    Kolb, J.
    Ostermann, T.
    Sappok, T.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2024, 68 (08) : 941 - 953
  • [39] Engagement of medication users in the development and implementation of digital medication adherence technologies: a multi-stakeholder study
    Hosszu, Dalma
    Dima, Alexandra L.
    Fernandez, Francisca Leiva
    Schneider, Marie Paule
    van Dijk, Liset
    Toth, Krisztina
    Duman, Mark
    Davis, Wendy
    Andriciuc, Cristian
    Egan, Rebecca
    Vrijens, Bernard
    Kardas, Przemyslaw
    Bitterman, Noemi
    Mucalo, Iva
    Ghiciuc, Cristina Mihaela
    Agh, Tamas
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024, 24 (07) : 853 - 860
  • [40] Development and use of a checklist for the implementation of medication for opioid use disorder in jails
    Ludwig, Ariel
    Monico, Laura B.
    Blue, Thomas
    Gordon, Michael S.
    Schwartz, Robert P.
    Mitchell, Shannon Gwin
    IMPLEMENTATION RESEARCH AND PRACTICE, 2022, 3